Cardiff Oncology, Inc. (CRDF)
1.37
+0.07
(+5.38%)
USD |
NASDAQ |
Sep 18, 16:00
1.37
0.00 (0.00%)
After-Hours: 20:00
Cardiff Oncology Price to Book Value : 3.537 for Sept. 18, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 3.537 |
| September 17, 2026 | 3.356 |
| September 16, 2026 | 3.486 |
| September 15, 2026 | 3.460 |
| September 14, 2026 | 3.382 |
| September 11, 2026 | 3.124 |
| September 10, 2026 | 3.124 |
| September 09, 2026 | 2.711 |
| September 08, 2026 | 2.84 |
| September 04, 2026 | 2.814 |
| September 03, 2026 | 2.788 |
| September 02, 2026 | 2.737 |
| September 01, 2026 | 2.659 |
| August 31, 2026 | 2.565 |
| August 28, 2026 | 2.427 |
| August 27, 2026 | 2.546 |
| August 26, 2026 | 2.541 |
| August 25, 2026 | 2.634 |
| August 24, 2026 | 2.577 |
| August 21, 2026 | 2.272 |
| August 20, 2026 | 2.346 |
| August 19, 2026 | 2.318 |
| August 18, 2026 | 2.288 |
| August 17, 2026 | 2.335 |
| August 14, 2026 | 2.486 |
| Date | Value |
|---|---|
| August 13, 2026 | 2.540 |
| August 12, 2026 | 2.557 |
| August 11, 2026 | 2.711 |
| August 10, 2026 | 2.659 |
| August 07, 2026 | 2.561 |
| August 06, 2026 | 2.480 |
| August 05, 2026 | 2.466 |
| August 04, 2026 | 2.398 |
| August 03, 2026 | 2.411 |
| July 31, 2026 | 2.208 |
| July 30, 2026 | 2.197 |
| July 29, 2026 | 2.091 |
| July 28, 2026 | 2.112 |
| July 27, 2026 | 2.158 |
| July 24, 2026 | 2.135 |
| July 23, 2026 | 2.164 |
| July 22, 2026 | 2.220 |
| July 21, 2026 | 2.169 |
| July 20, 2026 | 2.165 |
| July 17, 2026 | 2.272 |
| July 16, 2026 | 2.258 |
| July 15, 2026 | 2.296 |
| July 14, 2026 | 3.382 |
| July 13, 2026 | 3.486 |
| July 10, 2026 | 3.434 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.595 |
| Alnylam Pharmaceuticals, Inc. | 23.66 |
| Anika Therapeutics, Inc. | 2.029 |
| Savara, Inc. | 7.678 |
| Vericel Corp. | 5.534 |
Price to Book Value Related Metrics
| PS Ratio | 183.08 |
| Price | 1.37 |
| Earnings Yield | -43.11% |
| Market Cap | 93.85M |